Predictive Value of Intratumoral Microvascular Density in Patients with Advanced Non-small Cell Lung Cancer Receiving Chemotherapy Plus Bevacizumab

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Medicine, Oncology, Pharmacology +13

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso et al. · Nature Medicine · 2004 · 2K citations · Full text

Medicine, Cancer Biology, Oncology +17

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

Laura E. Benjamin, Dragan Golijanin, Ahuva Itin et al. · Journal of Clinical Investigation · 1999 · 1.2K citations · Full text

Medicine, Cancer Biology, Oncology +17

Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.

A. Eberhard, Sebastian Kahlert, Valentin Goede et al. · PubMed · 2000 · 755 citations

Medicine, Oncology, Pathology +17

Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer

Adrian M. Jubb, Herbert I. Hurwitz, Wei Bai et al. · Journal of Clinical Oncology · 2005 · 389 citations · Full text

Medicine, Oncology, Pharmacology +17